Navigation Links
Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer

IRVING, Texas--(BUSINESS WIRE)--Apr 25, 2007 - Reata Pharmaceuticals, Inc. today announced the publication of a review article covering the company's Synthetic Triterpenoid programs in the May 2007 issue of the prestigious journal "Nature Reviews Cancer."

The article, "Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer," by researchers and Reata scientific collaborators from the Dartmouth Medical School Karen T. Liby, Mark M. Yore and Michael B. Sporn, focuses on two new classes of multifunctional drugs that it reports can prevent and treat cancer in experimental animals. One of Reata's lead clinical candidates, from one of the classes the article describes, the Synthetic Triterpenoids, is entering advanced clinical trials for deadly, late-stage cancers.

The article describes the Synthetic Triterpenoids as a new class of non-toxic and highly multifunctional drugs that have applications for the prevention and treatment of not only cancer, but also of many other diseases with an inflammatory component.

"An outstanding body of work is emerging on the Synthetic Triterpenoids from many top academic collaborators," commented Warren Huff, Reata's CEO. "Dr. Sporn and his team have provided an excellent summary of the broad research currently underway on these compounds and the underlying biological pathways they modulate. Reata is delighted to have the opportunity to collaborate with these researchers in taking take these important new drugs forward to provide a clinical benefit for patients with cancer and other diseases."

Reata in-licensed the complete series of Synthetic Triterpenoids from Dartmouth and the University of Texas M.D. Anderson Cancer Center in 2004. RTA 402, the lead agent from this series, has recently begun Phase 2 clinical studies for cancer and anti-inflammatory diseases. An ongoing Phase 1 study in cancer patients has demonstrated
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
4. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
5. Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
6. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
7. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
8. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reata Synthetic Triterpenoids Profiled Nature Reviews Cancer
(Date:5/6/2015)... 2015 AbbVie (NYSE: ABBV ) will ... Health Care Conference on Wednesday, May 13, 2015. ... will participate in a question and answer session at ... webcast of the presentation will be accessible through AbbVie,s ... archived edition of the session will be available later ...
(Date:5/6/2015)... May 6, 2015   Symbiomix Therapeutics today ... and final tranche of a $41 million Series A ... 2 trial testing a single oral dose of SYM-1219 ... discussions with the U.S. Food and Drug Administration (FDA) ... planning to submit the Phase 2 trial as one ...
(Date:5/6/2015)... STOCKHOLM , May 6, 2015   Wilson ... announced that CEO Jonas Hansson has been ... company during the annual BioEquity Conference, this year to ... CEST on May 19 th . ... tetrathiomolybdate, which is currently in Phase 2 testing for ...
Breaking Medicine Technology:Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 2Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 5Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna On May 19th 2
... and AMSTERDAM, August 10, 2011 Agendia, ... the 12th St. Gallen International Breast Cancer Conference (2011) ... - classifying patients by the particular biological subtype of ... cancer patients. According to the panel, "it is no ...
... is unpredictable and can be even more so when you ... sneezing or itchy, watery eyes just might earn you top ... Facebook.  Allergy sufferers are invited to upload a short video ... win $5,000 toward a fun-filled adventure where they can enjoy ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 2Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 4
(Date:5/5/2015)... Ras Al Khaimah, UAE (PRWEB) May 05, 2015 ... Grace Century , FZ LLC has announced that ... ’, monthly enrollment for Store-A-Tooth™ increased once again--in April, ... the company’s 40th month of increased record volume and ... , Marketing for Provia’s dental stem cell biobank is ...
(Date:5/5/2015)... Beverly Hills Cosmetic Dentist, Arthur Glosman released a ... be sold at the offices of Arthur Glosman DDS, 450 ... through an online store . “I wanted to be ... dental care and beauty with a luxurious collection of products ... Glosman. , Dr. Glosman’s Advanced Dental Health + Beauty™ ...
(Date:5/5/2015)... Scottsdale, AZ (PRWEB) May 05, 2015 ... NCPDP’s Elite Partner Program. The program establishes a three-year ... to a maximum of 10 Elite Partners. “AmerisourceBergen has ... Ann Stember, President of NCPDP, “and this is a ... work. , We can trace AmerisourceBergen back to ...
(Date:5/5/2015)... AxoGen, Inc. (NASDAQ: AXGN), a ... peripheral nerve repair market, reported record revenue of $4.95 ... compared to $3.14 million in the year-ago first quarter. ... portfolio of nerve repair products - Avance® Nerve ... and our solid sales execution delivered another record quarter ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... Health IVF Clinic in Greece, an experienced team ... and treatment of infertility for patients around the globe. ... partnered with VisitandCare.com. Greece unquestionably remains a global leader ... most talented and hard-working fertility specialists in the world ...
Breaking Medicine News(10 mins):Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3
... float the first 'global health bonds' to raise $ 4 ... poor, and strengthen global immunization efforts.// ,The move will ... world to become part of the efforts to make healthcare ... investment. ,Giving information about the bonds that are ...
... of Washington University writes in his latest book Doctor’s ... has been a great scientist, inventor, publisher and statesman.// ... education has contributed a lot to preventive and modern ... America during the 18th Century in a period where ...
... Improvement has funded a grant of $30,000 to Medical ... Care to understand the usefulness of online information systemhas ... online information system woulc be helpulf for managing multiple ... to apply and the 20 selected for support from ...
... by Brian Carpenter, Ph.D., of the Washington University in St. ... two adult siblings with regard to their parents’ wants. // ... across. There is nothing which clearly indicates as to which ... wants. ,The children who feel that they ...
... the brain spring into action when one if faced with ... Hsu of the California Institute of Technology in Pasadena and ... betting games. As they played, the scientists watched changes in ... one game, researchers gave them the chance to guess the ...
... basic vaccines and introduce three new ones.,"We will give India ... will provide $40 million and then more than double it ... ,Addressing a press conference after the conclusion of the ... made a lot of progress in the vaccination and immunization ...
Cached Medicine News:Health News:Health bonds to immunize the poor 2Health News:Online information system for patients 2Health News:Adult Children Fail to Understand Parents Wishes 2
Arthroscopic instrument system for instability and SLAP fixation....
Suture Cutter, straight...
... Mini-Open Rotator Cuff Repair System facilitates ... time, incision size and the likelihood ... rotator cuff repair systems and implants. ... of matched cortical gauge punches, circular ...
Suture Cutters, Straight...
Medicine Products: